Evidence map›Paper›PMID 22039520›Full record

ArticlePloS one2011

LL37 and cationic peptides enhance TLR3 signaling by viral double-stranded RNAs.

Yvonne Lai, Sreedevi Adhikarakunnathu, Kanchan Bhardwaj, C T Ranjith-Kumar, Yahong Wen, Jarrat L Jordan, Linda H Wu, Bogdan Dragnea, Lani San Mateo, C Cheng Kao

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 112 citations in OpenAlex.

  1. Review
  2. Article
  3. Human antimicrobial/host defense peptide LL-37 may prevent the spread of a local infection through multiple mechanisms: an update.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. New insight into the biological activity ofFrontiers in immunology · 2024
    Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Yvonne LaiDepartment of Molecular and Cellular Biochemistry, Indiana University, Bloomington, Indiana, United States of America. yylai@indiana.edu
Sreedevi Adhikarakunnathu
Kanchan Bhardwaj
C T Ranjith-Kumar
Yahong Wen
Jarrat L Jordan
Linda H Wu
Bogdan Dragnea
Lani San Mateo
C Cheng Kao
Indiana University Bloomington · US

Funding

Proteome-wide identification of RNA-binding proteinsR21AI075015 · NIAID · TRUSTEES OF INDIANA UNIVERSITY · PI KAO, CHENG C · 2009 to 2010
$444k
NIAID NIH HHS R21 AI075015PHS HHS RAI075015A
6 · The paper itself

Abstract

backgroundToll-like Receptor 3 (TLR3) detects viral dsRNA during viral infection. However, most natural viral dsRNAs are poor activators of TLR3 in cell-based systems, leading us to hypothesize that TLR3 needs additional factors to be activated by viral dsRNAs. The anti-microbial peptide LL37 is the only known human member of the cathelicidin family of anti-microbial peptides. LL37 complexes with bacterial lipopolysaccharide (LPS) to prevent activation of TLR4, binds to ssDNA to modulate TLR9 and ssRNA to modulate TLR7 and 8. It synergizes with TLR2/1, TLR3 and TLR5 agonists to increase IL8 and IL6 production. This work seeks to determine whether LL37 enhances viral dsRNA recognition by TLR3. METHODOLOGY/PRINCIPAL

findingsUsing a human bronchial epithelial cell line (BEAS2B) and human embryonic kidney cells (HEK 293T) transiently transfected with TLR3, we found that LL37 enhanced poly(I:C)-induced TLR3 signaling and enabled the recognition of viral dsRNAs by TLR3. The presence of LL37 also increased the cytokine response to rhinovirus infection in BEAS2B cells and in activated human peripheral blood mononuclear cells. Confocal microscopy determined that LL37 could co-localize with TLR3. Electron microscopy showed that LL37 and poly(I:C) individually formed globular structures, but a complex of the two formed filamentous structures. To separate the effects of LL37 on TLR3 and TLR4, other peptides that bind RNA and transport the complex into cells were tested and found to activate TLR3 signaling in response to dsRNAs, but had no effect on TLR4 signaling. This is the first demonstration that LL37 and other RNA-binding peptides with cell penetrating motifs can activate TLR3 signaling and facilitate the recognition of viral ligands. CONCLUSIONS/SIGNIFICANCE: LL37 and several cell-penetrating peptides can enhance signaling by TLR3 and enable TLR3 to respond to viral dsRNA.

Indexed as

Amino Acid SequenceAntimicrobial Cationic PeptidesCathelicidinsCell LineHumansMicroscopy, ConfocalMolecular Sequence DataNucleic Acid ConformationPoly I-CRhinovirusRNA, Double-StrandedSequence Homology, Amino AcidSignal TransductionToll-Like Receptor 3Antimicrobial Cationic PeptidesCathelicidinsPoly I-CRNA, Double-StrandedTLR3 protein, humanToll-Like Receptor 3

Identifiers

PMID22039520
PMCPMC3198786
OpenAlexW2054805318

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.